NidlegyTM
Preclinical
Phase I
Phase II
Phase III
Stage III B,C Melanoma (EU)
–
–
–
–
Stage III B,C Melanoma (US)
–
–
–
–
Stage IV Melanoma
–
–
–
–
Nonmelanoma Skin Cancer (BCC/SCC)
–
–
–
–
Fibromun
Preclinical
Phase I
Phase II
Phase III
+ Doxorubicin – 1st line Soft-Tissue Sarcoma (EU)
–
–
–
–
+ Doxorubicin – 1st line Leiomyosarcoma (US)
–
–
–
–
+ Dacarbazine – pre-treated Soft-Tissue Sarcoma (EU)
–
–
–
–
Monotherapy – recurrent Glioma (CH)
–
–
–
–
+ Lomustine – recurrent Glioma (EU)
–
–
–
–
+ Radiation + Temozolomide – 1st line Glioma (EU)
–
–
–
–
Darleukin
Preclinical
Phase I
Phase II
Phase III
+ Radiation – Non-Small Cell Lung Cancer
–
–
–
–
Dodekin
Preclinical
Phase I
Phase II
Phase III
Various Solid Tumors
–
–
–
–
Dekavil
Preclinical
Phase I
Phase II
Phase III
Chronic Inflammation
–
–
–
–
ABBV-022
Preclinical
Phase I
Phase II
Phase III
Ulcerative Colitis
–
–
–
–
Onco IX
Preclinical
Phase I
Phase II
Phase III
Renal Cell Carcinoma
–
–
–
–
Onco FAP
Preclinical
Phase I
Phase II
Phase III
Various Solid Tumors
–
–
–
–
FAP-IL12
Preclinical
Phase I
Phase II
Phase III
Undisclosed
–
–
–
–
Tripokin
Preclinical
Phase I
Phase II
Phase III
Undisclosed
–
–
–
–